Research study Program year 2022 Source: CMS Open Payments

101Hemb02

Research payments

$40,449

22 payments

Through program year 2022, $40,449 in research payments was reported against 101Hemb02, across 22 payments, paid by Ultragenyx Pharmaceutical Inc..

Paid by: Ultragenyx Pharmaceutical Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

3 rows

Year	Kind	Amount	Payments
2022	Research	$21,490	14
2021	Research	$11,078	3
2020	Research	$7,882	5

Breakdown

Who paid Research payments · program years 2020–2022

Ultragenyx Pharmaceutical Inc. $40,449 22 payments

Who received the money Research payments · program years 2020–2022

Univ Of Mi Hospitals & Hlth Ctrs Teaching hospital · MI $12,314 6 payments
Arkansas Childrens Research Organisation paid for research $11,610 6 payments
University of Florida Organisation paid for research $11,209 8 payments
Arkansas Childrens Research Institute Organisation paid for research $3,817 1 payment
Arkansas Children S Research Organisation paid for research $1,500 1 payment

Usually the institution or organisation running the study, not a person.

What the money was spent on Research payments · program years 2020–2022

Patient care $7,882 5 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

3 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.